Acadian Asset Management
KZIA

Acadian Asset Management’s Kazia Therapeutics KZIA Stock Holding History

Acadian Asset Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-374
Closed -$8K – 1685
2023
Q4 		$8K Hold
374
– – ﹤0.01% 1630
2023
Q3 		$18K Sell
374
-990
-73% -$48.3K ﹤0.01% 1553
2023
Q2 		$77K Hold
1,364
– – ﹤0.01% 1456
2023
Q1 		$70K Sell
1,364
-719
-35% -$34.5K ﹤0.01% 1464
2022
Q4 		$64K Sell
2,083
-1,265
-38% -$47.6K ﹤0.01% 1528
2022
Q3 		$183K Buy
+3,348
New +$374K ﹤0.01% 1231
2020
Q4 		– Sell
-19
Closed -$6K – 2276
2020
Q3 		$6K Buy
+19
New +$5.35K ﹤0.01% 2132
2018
Q4 		– Sell
-48
Closed -$8K – 1772
2018
Q3 		$8K Sell
48
-114
-70% -$19.4K ﹤0.01% 1570
2018
Q2 		$24K Hold
162
– – ﹤0.01% 1506
2018
Q1 		$45K Buy
+162
New +$37.5K ﹤0.01% 1377

Other funds holding KZIA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $1.93B AUM 18.43% 1-Year Est. Return

Acadian Asset Management's KZIA Position: Q1 2024 in Review

Acadian Asset Management sold out of Kazia Therapeutics (KZIA) in Q1 2024, closing a stake of 374 shares — an estimated $8K sold.

Acadian Asset Management first reported a position in KZIA in Q1 2018 and held it in 10 quarters. The position peaked at $183K in Q3 2022. 9 funds tracked by Wall St. Rank hold KZIA as of Q1 2024.

  • Acadian Asset Management reported no remaining Kazia Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Acadian Asset Management sold 374 Kazia Therapeutics shares in Q1 2024, an estimated $8K.
  • Acadian Asset Management first reported a position in Kazia Therapeutics in Q1 2018 and held it in 10 quarters.
  • Acadian Asset Management's Kazia Therapeutics position peaked at $183K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.